Home
Covid-19
Tools
TRIPS Flexibilities Database
Resources
Blog
About

Search

Medicines Law & Policy Research and resources on intellectual property and health

Home
Covid-19
Tools
TRIPS Flexibilities Database
Resources
Blog
About

Tag: USTR Special 301

Wrapping up 2019 – Noteworthy Medicines Law and Policy Events

Ellen 't Hoen - December 30, 2019

Recent Posts

Lessons for a pandemic preparedness treaty from previous successes and failures with treaty-based technology transfer.
The EU proposed Covid waivers of certain TRIPS rules are mostly meaningless
WHO’s Essential Medicines Committee takes aim at rising prices, adds new treatments for cancer care and diabetes treatment
Vaccine knowledge needs to be a global public good: Remarks to the World Trade Organization-World Health Organization High-Level Dialogue

Posts by Subject

Access to Medicines ARIPO C-TAP Cancer CDCA competition law Compulsory licensing compulsory licensing for export covid-19 Covid-19 Pool Covid-19 vaccine Data exclusivity Delinkage DNDi dolutegravir European Commission European Union evergreening Fair Pricing Gilead Hepatitis C HIV IFPMA LDCs market exclusivity Medicines Patent Pool Medicines Pricing Netherlands orkambi Orphan Drugs Patents PrEP R&D remdesivir Sofosbuvir SPC Supplementary Protection Certificates The Netherlands transparency TRIPS flexibilities Truvada vaccines WHO WIPO WTO

Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at: office@medicineslawandpolicy.net.

Home
Covid-19
Tools
TRIPS Flexibilities Database
Resources
Blog
About

This work is licensed under Creative Commons.